We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Postsurgical Otorrhea Severity Not Influenced by Pathogen Type

By HospiMedica International staff writers
Posted on 04 Jan 2012
Otitis media infections associated with methicillin-resistant Staphylococcus aureus (MRSA) following pediatric tympanostomy tube placement did not result in worse outcomes than those caused by other pathogens, according to a new study.

Researchers at the Children's Hospital of Alabama (Birmingham, USA) conducted a retrospective review of the medical records of 1,079 children who presented at the children's hospital from January 1, 2003, to December 31, 2008, with otorrhea that occurred after tympanostomy tube insertion. More...
Culture records were used to group the patients into those whose infection was due to MRSA (170 patients) and those with non-MRSA otitis media (909 patients). The researchers also randomly selected an age-matched group of 170 children and examined the differences between the MRSA and age-matched non-MRSA groups in organisms isolated by culture, demographic factors, medical history, treatments, surgical procedures performed, audiometric data, and other admissions for infection-related illnesses.

The results showed that of the 170 eligible children in each age-matched group, 135 with MRSA otorrhea and 141 with non-MRSA otorrhea had data in every category selected for statistical analysis. The groups did not differ significantly in medical insurance type, history of tympanostomy tube placement, cholesteatoma, number or type of surgical procedures performed, or risk of subsequent infection-related diagnoses. However, more patients in the MRSA group received the addition of oral antibiotics (40.7% vs. 24.8%) and intravenous (IV) antibiotic therapy (11% vs. 3.6%). The study was published in the December 2011 issue of Archives of Otolaryngology - Head & Neck Surgery.

“Treatment of MRSA otorrhea has undergone substantial changes over the last 10 years; many of the first patients with culture-proven MRSA otorrhea were hospitalized for a two-week course of parenteral antibiotics and were more likely to undergo mastoidectomy if they developed chronic infection of middle ear mucosa or granulation tissue,” said lead author Brian Wiatrak, MD, and colleagues of the pediatric ear, nose, and throat (ENT) department. “We believe that our selection of specific antibiotic agent based on the culture results and scrupulous attention to infection control practices helps to decrease the risk of new drug resistances developing.”

Otitis media is an inflammation of the middle ear that occurs in the area between the tympanic membrane and the inner ear, including a duct known as the eustachian tube. Though painful, otitis media is not threatening and usually heals on its own within 2–6 weeks. In chronic cases with effusions, insertion of a tympanostomy tube into the eardrum reduces recurrence rates in the six months after placement, but has little effect on long-term hearing. Thus, tubes are recommended in those who have more than three episodes of acute otitis media in six month or four in a year associated with an effusion.

Related Links:

Children's Hospital of Alabama



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.